DIVIS LABORATORIES
Back to Income Statement
|
DIVIS LABORATORIES Last 5 Year Operating Profit History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Operating Profit (Excl OI) | ₹2,969 Cr | ₹2,206 Cr | ₹2,369 Cr | ₹3,881 Cr | ₹2,861 Cr |
What is the latest Operating Profit of DIVIS LABORATORIES ?
Year | Operating Profit |
---|---|
Mar2025 | ₹2,969 Cr |
Mar2024 | ₹2,206 Cr |
Mar2023 | ₹2,369 Cr |
Mar2022 | ₹3,881 Cr |
Mar2021 | ₹2,861 Cr |
How is Operating Profit of DIVIS LABORATORIES Trending?
Years | Operating Profit | % Change | |
---|---|---|---|
Mar2025 | ₹2,969 Cr | 34.59 | |
Mar2024 | ₹2,206 Cr | -6.88 | |
Mar2023 | ₹2,369 Cr | -38.96 | |
Mar2022 | ₹3,881 Cr | 35.65 | |
Mar2021 | ₹2,861 Cr | - |
Compare Operating Profit of peers of DIVIS LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
DIVIS LABORATORIES | ₹175,741.1 Cr | -1.7% | 0.5% | 47.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹405,991.0 Cr | -0.1% | 1.3% | 5% | Stock Analytics | |
CIPLA | ₹120,133.0 Cr | 0.4% | -1.5% | -1.6% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹118,994.0 Cr | -0.2% | 9% | 13.3% | Stock Analytics | |
MANKIND PHARMA | ₹106,806.0 Cr | -2.5% | 12.1% | 25% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,562.0 Cr | 0.5% | -5.7% | -9.1% | Stock Analytics |
DIVIS LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
DIVIS LABORATORIES | -1.7% |
0.5% |
47.2% |
SENSEX | -0.1% |
0.2% |
2.1% |
You may also like the below Video Courses